Back to top of page

Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)

- Name of the drug(s)

- Description of the shared molecular etiologies targeted

- List of rare diseases being studied

- Explanation of how the proposed clinical trial will target these shared molecular etiologies

- Explanation of how the proposed clinical trial will leverage existing datasets

- Collaborations with RDCRN clinical investigators

- Timeline for clinical trial start-up

- Budget for the clinical trial

- Plans for data collection and analysis

- Plans for patient recruitment and informed consent processes

- Plans for monitoring and assessing the safety and efficacy of the drug(s)

- Plans for dissemination of trial results

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows